# Evaluation of Long-term Efficacy of Treatment With Lamazym

> **NCT02478840** · PHASE3 · COMPLETED · sponsor: **Zymenex A/S** · enrollment: 18 (actual)

## Conditions studied

- Alpha-Mannosidosis

## Interventions

- **DRUG:** Lamazym

## Key facts

- **NCT ID:** NCT02478840
- **Lead sponsor:** Zymenex A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02478840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02478840, "Evaluation of Long-term Efficacy of Treatment With Lamazym". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02478840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*